DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION - AN ANALYSIS OF PATIENTS UNDERGOING CARDIOVERSION

被引：1
|
作者：
Koti, Meghashyam J.
Parekh, Amit
Connolly, Stuart J.
Wallentin, Lars
Reilly, Paul A.
Yusuf, Salim
Nagarakanti, Rangadham
Pogue, Janice
Flaker, Gregory C.
Ezekowitz, Michael D.
机构：
[1] Lankenau Inst Med Res, Wynnewood, PA USA
[2] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada
[3] Hamilton Hlth Sci, Hamilton, ON, Canada
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2010年 / 55卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1078-124
引用
收藏
页数：1
相关论文
共 50 条
  • [21] TWO DOSAGES DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH HIGH RISK OF STROKE AND EMBOLISM UNDERGOING ELECTRICAL CARDIOVERSION WITH PERSISTENT AND LONG-ACTING ATRIAL FIBRILLATION
    Kalejs, Oskars
    Litunenko, Olga
    Vikmane, Maija
    Sakne, Sandis
    Zabunova, Milana
    Strelnieks, Aldis
    Lurina, Baiba
    Sime, Iveta
    Kovalova, Marina
    Kupics, Kaspars
    Lejnieks, Aivars
    Erglis, Andrejs
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A353 - A353
  • [22] Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation
    Dzeshka, Mikhail S.
    Lip, Gregory Y. H.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (01) : 45 - 62
  • [23] Inpatient versus outpatient management of atrial fibrillation in patients undergoing cardioversion
    Shishehbor, MH
    Murray, RD
    Jasper, S
    Apperson-Hanson, C
    Black, IW
    Stoddard, MF
    Grimm, RA
    Klein, AL
    [J]. CIRCULATION, 2002, 106 (19) : 706 - 706
  • [24] Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis
    Providencia, Rui
    Albenque, Jean-Paul
    Combes, Stephane
    Bouzeman, Abdeslam
    Casteigt, Benjamin
    Combes, Nicolas
    Narayanan, Kumar
    Marijon, Eloi
    Boveda, Serge
    [J]. HEART, 2014, 100 (04) : 324 - 335
  • [25] HEALTH CARE COST IN PATIENTS UNDERGOING ELECTRICAL CARDIOVERSION: AN ANALYSIS FROM THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) STUDY
    Barrrios, Rodriguez J.
    Goette, A.
    Kwong, J.
    Ezekowitz, M. D.
    Banach, M. S.
    Hjortshen, S. P.
    Zamcnyakhin, D.
    Lip, G.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A608 - A608
  • [26] DABIGATRAN VERSUS WARFARIN FOR ATRIAL FIBRILLATION IN COLOMBIA
    Alfonso-cristancho, R.
    Vecino, A., I
    Herran, S.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A121 - A121
  • [27] Dabigatran versus Warfarin in Patients with Atrial Fibrillation (vol 361, pg 1139, 2009)
    Connolly, Stuart J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19): : 1877 - 1877
  • [28] The Comparison of Therapeutic Efficacy Between Dabigatran Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation
    Li, Hongxia
    Zhang, Lei
    Xia, Ming
    Zhang, Chi
    Jiang, Tingbo
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
  • [29] Comparative Effectiveness of Dabigatran versus Warfarin in Patients With Non-Valvular Atrial Fibrillation
    Alonso, Alvaro
    Chen, Lin Y.
    MacLehose, Richard F.
    Lutsey, Pamela L.
    [J]. CIRCULATION, 2013, 128 (22)
  • [30] Left atrial thrombosis in patients with atrial fibrillation undergoing cardioversion
    Golubic, K.
    Vranesic, I. Ivanac
    Smalcelj, A.
    Milicic, D.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 902 - 902
12345